{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-004264","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2025-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.549861+00:00","generated_at":"2026-05-24T00:43:33.021494+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Coherus to repurchase $170M of convertible notes, conditional on UDENYCA sale close","bullets":["Coherus agreed to repurchase ~$170M aggregate principal of its 1.500% Convertible Notes due 2026 at 100% par plus accrued interest.","Repurchases conditioned on closing of UDENYCA franchise divestiture to Intas Pharmaceuticals, expected early Q2 2025.","After repurchase, ~$60M of notes remain; Coherus plans a repurchase offer for those notes post-close.","Holders representing a majority of outstanding notes consented to indenture amendments permitting the UDENYCA divestiture.","Amendments executed via supplemental indenture dated March 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-004264","json":"https://secwatch.observer/filing/0001558370-25-004264.json","markdown":"https://secwatch.observer/filing/0001558370-25-004264.md","text":"https://secwatch.observer/filing/0001558370-25-004264.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000155837025004264/0001558370-25-004264-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000155837025004264/chrs-20250331x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T00:43:33.021494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}